Credit Agricole’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Sell
290,612
-67,525
-19% -$2.9M 0.03% 415
2026
Q1
$13.2M Sell
358,137
-71,948
-17% -$3.41M 0.03% 337
2025
Q4
$21.9M Buy
430,085
+194,450
+83% +$9.94M 0.05% 266
2025
Q3
$13.1M Buy
+235,635
New +$13.8M 0.03% 348
2025
Q1
$2.09M Buy
30,152
+2,332
+8% +$193K 0.01% 734
2024
Q4
$2.39M Buy
27,820
+24,020
+632% +$2.6M 0.01% 708
2024
Q3
$452K Buy
3,800
+2,108
+125% +$281K ﹤0.01% 967
2024
Q2
$242K Buy
1,692
+980
+138% +$130K ﹤0.01% 912
2024
Q1
$87.4K Buy
+712
New +$84.8K ﹤0.01% 766
2015
Q4
Sell
-42,222
Closed -$1.15M 1446
2015
Q3
$1.15M Buy
+42,222
New +$1.2M 0.01% 975

Other funds holding NVO

Credit Agricole's NVO Position: Q2 2026 in Review

Credit Agricole reduced its Novo Nordisk (NVO) stake by 19% in Q2 2026, selling an estimated $2.9M and leaving 290,612 shares worth $13.9M. The position accounts for 0.03% of the portfolio, ranked #415.

Credit Agricole first reported a position in NVO in Q3 2015 and has held it in 10 quarters since. The position peaked at $21.9M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Credit Agricole held 290,612 shares of Novo Nordisk worth $13.9M as of Q2 2026.
  • Credit Agricole sold 67,525 Novo Nordisk shares in Q2 2026, an estimated $2.9M.
  • Novo Nordisk made up 0.03% of Credit Agricole's portfolio in Q2 2026, its #415 holding.
  • Credit Agricole first reported a position in Novo Nordisk in Q3 2015 and has held it in 10 quarters since.
  • Credit Agricole's Novo Nordisk position peaked at $21.9M in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.